Align Technology, Inc. $ALGN Shares Purchased by Hunter Perkins Capital Management LLC

Hunter Perkins Capital Management LLC grew its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 383.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 43,842 shares of the medical equipment provider’s stock after purchasing an additional 34,767 shares during the period. Align Technology accounts for 1.6% of Hunter Perkins Capital Management LLC’s portfolio, making the stock its 17th biggest position. Hunter Perkins Capital Management LLC owned approximately 0.06% of Align Technology worth $6,846,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Sentry Investment Management LLC grew its position in shares of Align Technology by 73.1% during the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 79 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new stake in Align Technology during the second quarter worth about $36,000. Miller Global Investments LLC bought a new position in Align Technology in the fourth quarter worth about $31,000. MUFG Securities EMEA plc acquired a new position in Align Technology in the second quarter valued at approximately $38,000. Finally, Steigerwald Gordon & Koch Inc. acquired a new position in Align Technology in the third quarter valued at approximately $26,000. 88.43% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Align Technology

In other Align Technology news, EVP John Morici sold 7,969 shares of Align Technology stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares in the company, valued at approximately $1,559,346.47. The trade was a 49.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.66% of the stock is currently owned by company insiders.

Align Technology Trading Down 6.2%

Shares of NASDAQ:ALGN opened at $166.38 on Friday. The company has a 50 day moving average of $177.15 and a 200-day moving average of $155.83. The firm has a market cap of $11.86 billion, a P/E ratio of 29.40, a P/E/G ratio of 1.81 and a beta of 1.79. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $208.30.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.30. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The business had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business posted $2.44 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Equities research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Analyst Ratings Changes

ALGN has been the subject of several recent research reports. Morgan Stanley upped their target price on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Stifel Nicolaus boosted their price objective on Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Mizuho upped their price objective on Align Technology from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their target price on Align Technology from $181.00 to $200.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Evercore raised their target price on Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Align Technology has a consensus rating of “Moderate Buy” and a consensus target price of $198.08.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.